Beta-sitosterols for benign prostatic hyperplasia - Wikidata - wikimedia - TriplyDB

Beta-sitosterols for benign prostatic hyperplasia

Beta-sitosterols for benign prostatic hyperplasia

http://www.wikidata.org/entity/Q28143571

about

sameAs

Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction Systematic reviews of complementary therapies - an annotated bibliography. Part 2: herbal medicine Plant sterols: factors affecting their efficacy and safety as functional food ingredients Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia Designing a 'NHS friendly' complementary therapy service: a qualitative case study.Qianliening capsule inhibits benign prostatic hyperplasia angiogenesis via the HIF-1α signaling pathway.Isolation, biological evaluation and validated HPTLC-quantification of the marker constituent of the edible Saudi plant Sisymbrium irio L Androgens and estrogens in benign prostatic hyperplasia: past, present and future.Stromal growth and epithelial cell proliferation in ventral prostates of liver X receptor knockout mice Natural therapies used by adult men for the treatment of erectile dysfunction, benign prostatic hyperplasia, and for augmenting exercise performance.Qianliening capsule treats benign prostatic hyperplasia via suppression of the EGF/STAT3 signaling pathway.

P2860

Q24186736-81D5CE3D-F6A2-4587-8F28-0784F4FC9247 Q24802805-8DA5C5FE-FC56-4C57-8DC6-2F6EC1030838 Q24803635-ADC00B0E-619B-4111-B19D-89224E52FF10 Q26741226-ADBA5316-B37B-4A7C-8CEF-93060FB98D1F Q30847210-5F75353E-C01B-42CE-B761-AD8E198439CE Q33769561-E9FA107D-CC3C-4078-9A65-4DA40E912B05 Q33896778-8AB05D5D-68A5-4652-A1C3-C86C52D9FEBB Q35231660-10662A2A-72EB-4B23-A6FC-70968DA3FB98 Q37062087-B2B9B379-BA27-4E2A-BB8D-25B2C1E732E2 Q37890138-0A8CF261-2920-4716-8B0B-FB57C6E27776 Q41484907-EA717E41-698D-44AA-BEA1-CEB5E502EC71

P2860

Beta-sitosterols for benign prostatic hyperplasia

http://www.wikidata.org/entity/Q28143571

description

1999 nî lūn-bûn

@nan

1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Beta-sitosterols for benign prostatic hyperplasia

@ast

Beta-sitosterols for benign prostatic hyperplasia

@en

Beta-sitosterols for benign prostatic hyperplasia

@nl

type

label

Beta-sitosterols for benign prostatic hyperplasia

@ast

Beta-sitosterols for benign prostatic hyperplasia

@en

Beta-sitosterols for benign prostatic hyperplasia

@nl

prefLabel

Beta-sitosterols for benign prostatic hyperplasia

@ast

Beta-sitosterols for benign prostatic hyperplasia

@en

Beta-sitosterols for benign prostatic hyperplasia

@nl

P1433

Q28143571-82D42771-704F-4886-95E6-845141B1444B

P1476

Q28143571-5959C592-F7E1-4D1F-B29B-C3904AC68F72

P2093

Q28143571-06A164AA-80DC-49EB-AC18-3134DCCF7DF6

Q28143571-1AE3B405-58CB-4E31-8DF8-459A18D8A9DC

Q28143571-24356940-67E5-49A4-AA29-33DD647E858A

Q28143571-41A7749C-7FAF-4336-B566-33C8A5074AC6

Q28143571-7F451D86-B28B-4637-8974-B71EE368BF55

Q28143571-8426C8AB-DB07-41BF-88B6-B53735918CCA

Q28143571-8829BB92-533B-42DF-9A37-76E12A4F0FF2

Q28143571-9EC6253E-4B44-4C18-A842-5DB8E3CA1E0B

Q28143571-B7019CC6-131A-400F-B11F-9F75A862E51E

Q28143571-C88FA6E8-3BB5-4E5F-8BFD-412E85A65149

P2860

Q28143571-071B3FE9-1295-4288-8426-4017FCECDDC5

Q28143571-08EFB4BD-7492-4410-9D9A-031E28008090

Q28143571-2307C930-A006-4D49-B866-43DB1E112BC6

Q28143571-5095C5C0-A1C6-4EBF-A384-F18D4CA05C91

Q28143571-729E979D-7979-4A88-8C6E-31C553152FBC

Q28143571-F06839AF-52DB-4C73-8B95-7D75BF0DCBCA

P304

Q28143571-3EE6FFBA-88A9-4CAA-AC49-C59B7671050C

P31

Q28143571-7B5D487C-1710-4E80-9D58-6149762AB7B6

P3181

Q28143571-736A59F6-4385-4DAC-B846-E4D8A5A49A4A

P356

Q28143571-5394D7B1-184E-4927-9479-5DAA3ECD6DBA

P407

Q28143571-8DFD5265-C8EB-4457-9564-A66F3242BC51

P433

Q28143571-6AA1BE59-6364-4DE8-ABA7-DBCA0988B8AF

P577

Q28143571-41A8AB2E-875C-461F-9579-92DF19179F5D

Q28143571-C0A03F30-D3F2-4F71-B99E-21F9B7A0A102

P698

Q28143571-4DEC4C33-8316-42EF-9424-3275F9599FCA

P3181

P356

14651858.CD001043

P1433

Cochrane Database of Systematic Reviews

P1476

Beta-sitosterols for benign prostatic hyperplasia

@en

P2093

A Ishani

http://www.w3.org/2001/XMLSchema#string

Areef Ishani

http://www.w3.org/2001/XMLSchema#string

C Mulrow

http://www.w3.org/2001/XMLSchema#string

Cynthia D Mulrow

http://www.w3.org/2001/XMLSchema#string

G Stark

http://www.w3.org/2001/XMLSchema#string

Gerold Stark

http://www.w3.org/2001/XMLSchema#string

J Lau

http://www.w3.org/2001/XMLSchema#string

Joseph Lau

http://www.w3.org/2001/XMLSchema#string

R MacDonald

http://www.w3.org/2001/XMLSchema#string

Roderick MacDonald

http://www.w3.org/2001/XMLSchema#string

P2860

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

beta-sitosterol for the treatment of benign prostatic hyperplasia: a systematic review.

Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group.

Benign prostatic hyperplasia. Medical and minimally invasive treatment options.

Phytotherapy in treatment of benign prostatic hyperplasia: a critical review.

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials

P304

CD001043

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3993248

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/14651858.CD001043

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P577

1999-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2000-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10796740

http://www.w3.org/2001/XMLSchema#string